The R7 Subfamily of RGS Proteins Assists Tachyphylaxis and Acute Tolerance at μ-Opioid Receptors

Neuropsychopharmacology

Volumn 28, Issue 11, 2003, Pages 1983-1990

  Garzón, Javier ^a,b   López Fando, Almudena ^a   Sánchez Blázquez, Pilar ^a  

^a CSIC   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Antinociception; Antisense technology; G proteins; Mouse brain; Regulator of G protein signaling

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA ENDORPHIN; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MU OPIATE RECEPTOR; RGS PROTEIN; RGS11 PROTEIN; RGS6 PROTEIN; RGS7 PROTEIN; RGS9-2 PROTEIN; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TACHYPHYLAXIS;

EID: 19244367478     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300263     Document Type: Article

References (46)

1. Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE (1991). Selective blockage of δ opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258: 299-303.
2. Axelrod JD, Miller JR, Shulman JM, Moon RT, Rerrimon N (1998). Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and Wingless signaling pathways. Genes Dev 12: 2610-2622.
3. Betty M, Harnish SW, Rhodes KJ, Cockett MI (1998). Distribution of heterotrimeric G-protein β and γ subunits in the rat brain. Neuroscience 85: 475-486.
4. Garzón J, Castro M, Sánchez-Blázquez P (1998). Influence of Gz and Gi2 transducer proteins in the affinity of opioid agonists to μ receptors. Eur J Neurosci 10: 2557-2564.
5. Garzón J, DeAntonio I, Sánchez-Blázquez P (2000). In vivo modulation of G-proteins and opioid receptor function by antisense oligodeoxynucleotides. Meth Enzymol 314: 3-20.
6. oα subunits restore the efficacy of opioids, clonidine and neurotensin giving rise to antinociception in G-protein knock-down mice. Neuropharmacology 38: 1861-1873.
7. Garzón J, Rodríguez-Díaz M, López-Fando A, García-España A, Sánchez-Blázquez P (2002). Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain. Neuropharmacology 42: 813-828.
8. Garzón J, Rodríguez-Díaz M, López-Fando A, Sánchez-Blázquez P (2001). RGS9 proteins facilitate acute tolerance to mu-opioid effects. Eur J Neurosci 13: 801-811.
9. i2α subunits prevents acute tolerance (tachyphylaxis) to mu-opioid effects in mice. Neuropharmacology 40: 560-569.
10. Gold SJ, Ni YG, Dohlmam HG, Nestler EJ (1997). Regulators of G-protein signaling (RGS) proteins; region-specific expression of nine subtypes in rat brain. J Neurosci 17: 8024-8037.
11. Granneman JG, Zhai Y, Zhu Z, Bannon MJ, Burchett SA, Schmidt CJ et al (1998). Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene. Mol Pharmacol 54: 687-694.
12. Hepler JR (1999). Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci 20: 376-382.
13. Hollinger S, Hepler JR (2002). Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 54: 527-559.
14. Huidobro-Toro JP, Way EL (1978). Single-dose tolerance to antinociception, and physical dependence on β-endorphin in mice. Eur J Pharmacol 52: 179-189.
15. Jensen TS, Yaksh TL (1986). III. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal grey matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Brain Res 372: 301-312.
16. Kest B, Lee CE, Mclemore GL, Inturrisi CE (1996). An antisense oligodeoxynucleotide to the δ opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res Bull 39: 185-188.
17. Kim E, Arnould T, Sellin L, Benzing T, Comelia N, Kocher O et al (1999). Interaction between RGS7 and polycystin. Proc Natl Acad Sci USA 96: 6371-6376.
18. Levac BA, O'Dowd BF, George SR (2002). Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol 2: 76-81.
19. Munson PJ, Rodbard D (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239.
20. Miyamoto Y, Portoghese PS, Takemori AE (1993). Involvement of δ2 opioid receptors in the development of morphine dependence in mice. J Pharmacol Exp Ther 264: 1141-1145.
21. Ni YG, Gold SJ, Iredale PA, Terwilliger RZ, Duman RS, Nestler EJ (1999). Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci 19: 3674-3680.
22. Nitsche JF, Schuller AGP, King MA, Zengh M, Pasternak GW, Pintar JE (2002). Genetic dissociation of opiate tolerance and physical dependence in δ-opioid receptor-1 and preproenkephalin knock-out mice. J Neurosci 22: 10906-10913.
23. Posner BA, Gilman AG, Harris BA (1999). Regulators of G protein signaling 6 and 7. Purification of complexes with Gβ5 and assessment of their effects on G protein-mediated signaling pathways. J Biol Chem 274: 31087-31093.
24. Rahman Z, Gold SJ, Potenza MN, Cowan CW, Ni YG, He W et al (1999). Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci 19: 2016-2026.
25. Rose JJ, Taylor JB, Cockett MI, Jones PG, Hepler JR (2000). RGS7 is palmitoylated and exists as biochemically distinct forms. J Neurochem 75: 2103-2112.
26. Ross EM, Wilkie TM (2000). GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Ann Rev Biochem 69: 795-827.
27. Rossi GC, Pasternak GW, Bodnar RJ (1994). μ and δ opioid synergy between the periaqueductal gray and the rostroventral medulla. Brain Res 665: 85-93.
28. + currents. J Biol Chem 14: 9899-9904.
29. Sánchez-Blázquez P, García-España A, Garzón J (1995). In vivo injection of oligodeoxynucleotides to Ga subunits and supra-spinal analgesia evoked by mu and delta opioid agonists. J Pharmacol Exp Ther 275: 1590-1596.
30. Sánchez-Blázquez P, García-España A, Garzón J (1997). Antisense oligodeoxynucleotides to opioid Mu and Delta receptors reduced morphine dependence in mice: role of Delta-2 opioid receptors. J Pharmacol Exp Ther 280: 1423-1431.
31. Sánchez-Blázquez P, Garzón J (1993). Opioid supraspinal antinociception in mice is mediated by Gi3 transducer proteins. Life Sci/Pharmacol Lett 53: PL129-PL134.
32. Sánchez-Blázquez P, Garzón J (1998). Delta opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J Pharmacol Exp Ther 285: 820-827.
33. Sánchez-Blázquez P, Juarros JL, Martínez-Peña Y, Castro MA, Garzón J (1993). Gx/z and Gi2 transducer proteins on μ/δ opioid-mediated supraspinal antinociception. Life Sci/Pharmacol Lett 53: PL381-PL386.
34. Sánchez-Blázquez P, Rodríguez-Díaz M, López-Fando A, Rodrí-guez-Muñoz M, Garzón J (2003). The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects. Neuropharmacology 45: 82-95.
35. Sierra DA, Popov S, Wilkie TM (2000). Regulators of G-protein signaling in receptor complexes. Trends Cardiovas Med 10: 263-228.
36. Snow BE, Krumins AM, Brothers GM, Lee S-F, Wall MA, Chung S et al (1998). A G protein γ subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gβ5 subunits. Proc Natl Acad Sci USA 95: 13307-13312.
37. Sondek J, Siderovski DP (2001). Gγ-like (GGL) domains: new frontiers in G-protein signaling and beta-propeller scaffolding. Biochem Pharmacol 61: 1329-1337.
38. Standifer KM, Rossi GC, Pasternak GW (1996). Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits. Mol Pharmacol 50: 293-298.
39. Thomas EA, Danielson PE, Sutcliffe JG (1998). RGS9: a regulator of G-protein signalling with specific expression in rat and mouse striatum. J Neurosci Res 52: 118-124.
40. Watson AJ, Aragay AM, Slepak VZ, Simon MI (1996). A novel form of the G protein β subunit Gβ5 is specifically expressed in the vertebrate retina. J Biol Chem 271: 28154-28160.
41. Watson AJ, Katz A, Simon MI (1994). A fifth member of the mammalian G-protein β-subunit family. J Biol Chem 269: 22150-22156.
42. Yaksh TL, Yeung JC, Rudy TA (1976). Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the peria-queductal grey. Brain Res 114: 83-103.
43. Zhang J-H, Lai Z, Simonds WF (2000). Differential expression of the G protein β5 gene: analysis of mouse brain, peripheral tissues, and cultured cell lines. J Neurochem 75: 393-403.
44. Zhang JH, Simonds WF (2000). Copurification of brain G-protein β5 with RGS6 and RGS7. J Neurosci 20, RC59 (1-5).
45. Zheng B, Ma YC, Ostrom RS, Lavoie C, Gill GN, Insel GN et al (2001). RGS-PX1, a GAP for Gαs and sorting nexin in vesicular trafficking. Science 30: 1939-1942.
46. Zhu Y, King MA, Schuller AGP, Nitsche JF, Reidi M, Elde RP et al (1999). Retention of supraspinal delta-like analgesia and loss of morphine tolerance in δ opioid receptor kockout mice. Neuron 24: 243-252.